Dexco SA

As of June 30, 2026, Dexco SA carries a market capitalization of 4.51B, placing it among publicly traded companies globally. Its enterprise value stands at 8.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Dexco SA's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Dexco SA has 907.87M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Dexco SA maintains a current ratio of 1.98, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Dexco SA recorded an income tax benefit of -58.80M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, Dexco SA's stock has gained approximately 71.21% over the past 52 weeks. The 50-day moving average sits at 5.98, while the 200-day moving average is 5.36.

As of June 30, 2026, Dexco SA holds 2.68B in cash and equivalents against 5.97B in total debt, resulting in a net debt position of 2.65B. Total book value stands at 6.92B, with working capital of 3.19B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Dexco SA paid dividends of 0.05 per share.

Dexco SA's most recent stock split took place on December 26, 2025 with a 25:28 split ratio.